Para conmemorar este día, desde La RED hemos preparado una infografía sobre los avances más relevantes en el campo de la prevención de los accidentes cerebrovasculares. ¡No te la pierdas!
No te pierdas los últimos avances en la prevención de los accidentes cerebrovasculares
Referencia
Fuentes:
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute
stroke treatment. Stroke 1993;24:35-41.
Chang A, Ricci B, Gory BM, Cutting S, Burton T, Dakay K, et al. Cardiac Biomarkers Predict Large Vessel Occlusion in Patients with Ischemic Stroke. J Stroke Cerebrovasc Dis 2019;28(6):1726-1731.
Diener HC, Foerch C, Riess H, Röther J, Schroth G and Weber R. Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment. Lancet Neurol 2013;12(7):677-688.
Estirado-Fugarolas H and Maldonado-Meléndez M. Implementation of the stroke code registry in the emergency department of a regional hospital. Enferm Clin 2019;29(1):47-53.
Feigin VL, Norrving B and Mensah GA. Global Burden of Stroke. Circ Res 2017;120(3):439-448.
García Fernández MA, Bermejo J and Moreno M. Image techniques for the evaluation and clinical decision making of patients with stroke. Rev Esp Cardiol 2003;56(11):1119-1132.
Gurol ME. Nonpharmacological management of atrial fibrillation in patients at high intracranial hemorrhage risk. Stroke 2018;49:247-254.
Gurol ME and Kim JS. Advances in Stroke Prevention in 2018. J Stroke. 2018;20(2):143–144.
Maaijwee NA, Rutten-Jacobs Lc, Schaapsmeerders P, van Dijk EJ and de Leeuw FE. Ischaemic stroke in young adults: risk factors and long-term consequences. Nat Rev Neurol 2014; 10(6):315-325.
Meisel K, Yuan K, Fang Q, Bibby D, Lee R and Schiller NB. Embolic Stroke of Undetermined Source: A Population with Left Atrial Dysfunction. J Stroke Cerebrovasc Dis 2019;28(7):1891-1896.
Moon I, Choi EK, Jung JH, Han KD, Choi YJ, Park J, et al. Ankylosing spondylitis: A novel risk factor for atrial fibrillation - A nationwide population-based study. Int J Cardiol 2019;275:77-82.
Mtwesi V, Amit G. Stroke Prevention in Atrial Fibrillation: The Role of Oral Anticoagulation. Med Clin North Am 2019;103(5):847-862.
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the Early Management on Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American
Heart Association/American Stroke Association. AHA J 2018;49:e49-e99.
Sheng S, Wu L, Nalleballe K, Sharma R, Brown A, Ranabothu S, et al. Fabry’s disease and stroke: Effectiveness of enzyme replacement therapy (ERT) in stroke prevention, a review with meta-analysis. J Clin Neurosci
2019;65:83-86.
Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, et al. The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial
fibrillation. Eur Heart J 2018;39:1330-1393.
Topcuoglu MA, Liu L, Kim DE, Gurol ME. Updates on prevention of cardioembolic strokes. J Stroke 2018;20:180-196.
Tsai HH, Kim JS, Jouvent E, Gurol ME. Updates on prevention of hemorrhagic and lacunar strokes. J Stroke 2018;20:167-179.
Tsivgoulis G, Safouris A, Kim DE, Alexandrov AV. Recent advances in primary and secondary prevention of atherosclerotic stroke. J Stroke 2018;20:145-166.
Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol 2013;12:483-497.
Aceptar y salir
